Paper41353995
Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax.
Reiten IN and 8 others. Transl Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax. Papers, record 41353995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41353995
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27103402 | Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27103402 | PubMed |
| 2 | 26375587 | Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs. | PLoS One | 2015 | https://conductscience.org/library/papers/26375587 | PubMed |
| 3 | 31203996 | Venetoclax-based therapies for acute myeloid leukemia. | Best Pract Res Clin Haematol | 2019 | https://conductscience.org/library/papers/31203996 | PubMed |
| 4 | 34117457 | Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/34117457 | PubMed |
| 5 | 30892988 | Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30892988 | PubMed |
| 6 | 28760346 | A defect in the mitochondrial protein Mpv17 underlies the transparent casper zebrafish. | Dev Biol | 2017 | https://conductscience.org/library/papers/28760346 | PubMed |
| 7 | 30679386 | A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia. | Mol Cancer Ther | 2019 | https://conductscience.org/library/papers/30679386 | PubMed |
| 8 | 30361262 | Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. | Blood | 2019 | https://conductscience.org/library/papers/30361262 | PubMed |
| 9 | 39538314 | Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AML. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/39538314 | PubMed |
| 10 | 34790781 | Synergistic effect of chidamide and venetoclax on apoptosis in acute myeloid leukemia cells and its mechanism. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34790781 | PubMed |
| 11 | 36355409 | A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae. | Biol Open | 2022 | https://conductscience.org/library/papers/36355409 | PubMed |
| 12 | 39581514 | Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cells. | Int J Pharm | 2025 | https://conductscience.org/library/papers/39581514 | PubMed |
| 13 | 9305600 | Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). | Leukemia | 1997 | https://conductscience.org/library/papers/9305600 | PubMed |
| 14 | 35797463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 | https://conductscience.org/library/papers/35797463 | PubMed |
| 15 | 38154071 | Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs. | Blood Adv | 2024 | https://conductscience.org/library/papers/38154071 | PubMed |
| 16 | 38928061 | Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928061 | PubMed |
| 17 | 41143709 | Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia. | Expert Opin Pharmacother | 2025 | https://conductscience.org/library/papers/41143709 | PubMed |
| 18 | 34124675 | New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells. | RSC Med Chem | 2021 | https://conductscience.org/library/papers/34124675 | PubMed |
| 19 | 30008477 | The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells. | Leukemia | 2019 | https://conductscience.org/library/papers/30008477 | PubMed |
| 20 | 29291023 | Combined venetoclax and alvocidib in acute myeloid leukemia. | Oncotarget | 2017 | https://conductscience.org/library/papers/29291023 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| NPM1 | 4869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41353995
GET https://conductscience.org/api/papers/v1/41353995/references?page=2